Hydrochloric Acid

Hydrochloric Acid

SCHEMBL10690050

Cl.NC(=O)NSCc1ccccc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 1/20 0.39
IDO1 P14902 6/20 0.50
NOS1 P29475 2/20 0.47
NOS3 P29474 1/20 0.47
NOS2 P35228 1/20 0.47
CYP2C19 P33261 2/20 0.43
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
PLA2G10 O15496 1/20 0.40
PLA2G2A P14555 1/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
KMT2A Q03164 1/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL133803 0.98 IDO1 (0.48) IDO1NOS1NOS3NOS2CYP2C19
SCHEMBL27639758 0.87 LMNA (0.47) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL3063086 0.84 IDO1 (0.43) IDO1NOS1NOS3NOS2CYP2C19
SCHEMBL27660548 0.83 AOC3 (0.50)
SCHEMBL3078872 0.83 IDO1 (0.46) IDO1NOS1NOS3NOS2CYP2C19
SCHEMBL3080810 0.82 CYP2C19 (0.47) IDO1NOS1NOS3NOS2CYP2C19
SCHEMBL7844886 0.82 SMN1; SMN2 (0.47) IDO1NOS1NOS3NOS2CYP2C19
Hydrochloric Acid SCHEMBL9627518 0.81 IDO1 (0.53) IDO1CYP2C19ALDH1A1HPGDLMNA
SCHEMBL3057987 0.81 IDO1 (0.44) IDO1NOS1NOS3NOS2CYP2C19
SCHEMBL13734757 0.81 NOS1 (0.48) NOS1CYP2C19ALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119192087-A Chemical synthesis method of ergothioneine 镇江卡博医药科技有限公司 2024-12-27 CN claimed
CN-117568805-A CO inhibition 2 Corrosion inhibitor for corrosion and preparation method and application thereof 西安石油大学 2024-02-20 CN claimed
CN-108529732-B Method for purifying iron-containing protein wastewater based on ionic liquid 河南师范大学 2021-05-25 CN claimed
CN-105017569-A Degradable composite tourist commodity packaging film and preparation method thereof JILIN TECHNOLOGY COLLEGE OF ELECTRONIC INFORMATION 2015-11-04 CN claimed
CN-119192087-A Chemical synthesis method of ergothioneine 镇江卡博医药科技有限公司 2024-12-27 CN disclosed
CN-113302185-B Benzofuran-6-carboxamide derivatives, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2024-04-09 CN disclosed
CN-117568805-A CO inhibition 2 Corrosion inhibitor for corrosion and preparation method and application thereof 西安石油大学 2024-02-20 CN disclosed
CN-113302185-A Benzofuran-6-carboxamide derivatives, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2021-08-24 CN disclosed
CN-108529732-B Method for purifying iron-containing protein wastewater based on ionic liquid 河南师范大学 2021-05-25 CN disclosed
CN-105924864-A Food plastic wrap and preparing method thereof 河南科技学院新科学院 2016-09-07 CN disclosed
CN-105017569-A Degradable composite tourist commodity packaging film and preparation method thereof JILIN TECHNOLOGY COLLEGE OF ELECTRONIC INFORMATION 2015-11-04 CN disclosed
CN-105017569-A Degradable composite tourist commodity packaging film and preparation method thereof JILIN TECHNOLOGY COLLEGE OF ELECTRONIC INFORMATION 2015-11-04 CN disclosed
US-4743598-A Antibacterial 2-(azacycloalkyl) penems SCHERING CORPORATION (US) 1988-05-10 US disclosed
EP-0109044-B1 PENEMS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PROCESS FOR PREPARING THEM SCHERING CORPORATION (US) 1986-10-15 EP disclosed
EP-0109044-A1 Penems, pharmaceutical compositions containing them, process for preparing them SCHERING CORPORATION (US) 1984-05-23 EP disclosed